Mercado de carbapenem: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00009276
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUCCIÓN AL MERCADO Los carbapenémicos son una clase de agentes antibióticos altamente efectivos que comúnmente se recomiendan para el tratamiento de infecciones bacterianas graves o de alto riesgo. Debido a sus propiedades antibióticas, los carbapenémicos desempeñan un papel importante en el tratamiento de enfermedades infecciosas. El medicamento se usa para tratar afecciones médicas observadas con frecuencia, como neumonía por aspiración, bacteriemia, infección bacteriana, infección ósea, bronquitis e infección profunda del cuello. DINÁMICA DEL MERCADO Es probable que la creciente prevalencia de infecciones bacterianas impulse el crecimiento del mercado mundial de carbapenems durante el período de pronóstico. Sin embargo, se prevé que la disponibilidad del producto en los países emergentes obstaculice el crecimiento del mercado de carbapenems. ALCANCE DEL MERCADO El "Análisis del mercado de carbapenems hasta 2031" es un estudio especializado y en profundidad de la industria farmacéutica con especial enfoque en el análisis de tendencias del mercado global. El informe tiene como objetivo proporcionar una descripción general del mercado de carbapenem con una segmentación detallada del mercado por tipo, indicaciones, canal de distribución y geografía. Se espera que el mercado de carbapenem sea testigo de un alto crecimiento durante el período de pronóstico. El informe proporciona estadísticas clave sobre el estado del mercado de los principales actores del mercado de carbapenem y ofrece tendencias y oportunidades clave en el mercado. SEGMENTACIÓN DEL MERCADO El mercado global de carbapenems está segmentado según el tipo, las indicaciones y el canal de distribución. Según el tipo, el mercado se segmenta en meropenem, doripenem, imipenem, tebipenem y otros. Según la indicación, el mercado se segmenta en meningitis bacteriana, infecciones pélvicas agudas, infecciones del tracto respiratorio y otras. Según el canal de distribución, el mercado se segmenta en farmacias minoristas, farmacias en línea y farmacias hospitalarias. El informe proporciona una descripción detallada de la industria que incluye información tanto cualitativa como cuantitativa. Proporciona una descripción general y un pronóstico del mercado global de carbapenem en función de varios segmentos. También proporciona el tamaño del mercado y estimaciones de pronóstico del año 2021 al 2031 con respecto a cinco regiones principales, a saber; América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur y Central. El mercado de carbapenems de cada región se subsegmenta posteriormente en los respectivos países y segmentos. El informe cubre el análisis y el pronóstico de 18 países a nivel mundial junto con las tendencias actuales y las oportunidades que prevalecen en la región. El informe analiza los factores que afectan el mercado de carbapenem tanto desde el lado de la oferta como de la demanda y evalúa en mayor profundidad la dinámica del mercado que afecta al mercado durante el período de pronóstico, es decir, impulsores, restricciones, oportunidades y tendencias futuras. El informe también proporciona un análisis PEST exhaustivo para las cinco regiones, a saber; América del Norte, Europa, APAC, MEA y América del Sur y Central después de evaluar los factores políticos, económicos, sociales y tecnológicos que afectan el mercado de carbapenems en estas regiones. JUGADORES DEL MERCADO El informe cubre desarrollos clave en el mercado de carbapenem como estrategias de crecimiento orgánico e inorgánico. Varias empresas se están centrando en estrategias de crecimiento orgánico como lanzamientos de productos, aprobaciones de productos y otros como patentes y eventos. Las estrategias de crecimiento inorgánico observadas en el mercado fueron adquisiciones, asociaciones y colaboraciones. Estas actividades han allanado el camino para la expansión de los negocios y la base de clientes de los actores del mercado. Se prevé que los actores del mercado de Carbapenem Market tendrán lucrativas oportunidades de crecimiento en el futuro con la creciente demanda de Carbapenem Market en el mercado global. A continuación se menciona la lista de algunas empresas que participan en el mercado de carbapenems. El informe también incluye los perfiles de empresas clave del mercado de carbapenem junto con su análisis FODA y estrategias de mercado. Además, el informe se centra en los principales actores de la industria con información como perfiles de empresas, componentes y servicios ofrecidos, información financiera de los últimos 3 años y desarrollos clave en los últimos cinco años. - Spero Therapeutics, Inc. - Savior Lifetec Corporation - Meiji Seika Pharma Co., Ltd. - Merck & Co., Inc. - Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.) - Aurobindo Pharma Ltd. - Daewoong Pharmaceutical Co ., Ltd. - Iterum Therapeutics plc - ACS Dobfar SpA El equipo dedicado de investigación y análisis de Insight Partner está formado por profesionales experimentados con conocimientos estadísticos avanzados y ofrece varias opciones de personalización en el estudio existente.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Carbapenem Market?

Carbapenem Market is expected to grow at a CAGR of 4.8% between 2023-2031

What are the driving factors impacting the Carbapenem Market?

The carbapenem market is primarily driven by the escalating prevalence of antibiotic-resistant infections. These infections, particularly those caused by multidrug-resistant bacteria, pose a significant threat to global health. Carbapenems, often considered a last-line defense against these infections, are essential for treating severe bacterial infections. Additionally, the rising healthcare expenditure globally, coupled with the growing geriatric population, is fueling the demand for effective antibiotics like carbapenems. Furthermore, product advancements in drug discovery and development are also pushing the market ahead, as this will ensure innovations in formulations and combination therapies.

What are the future trends of the Carbapenem Market?

Trends driving the future of the carbapenem market include persistent increases in antibiotic-resistant infections, which will drive demand for appropriate antibiotics such as carbapenems. Further developments in pharmaceutical drug discovery and development, such as the creation of innovative formulations and combination therapies, will enhance the efficacy and safety of carbapenems. Infection prevention and control measures have become an area of higher concern in the healthcare sector, so growth in the market will be encouraged through these factors. However, market growth may be affected by potential obstacles such as resistance to carbapenem-based bacteria and strict regulation.

Which are the leading players operating in the Carbapenem Market?

The leading players of the market are: Spero Therapeutics, Inc., Savior Lifetec Corporation, Meiji Seika Pharma Co., Ltd., Merck & Co., Inc., Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.), Aurobindo Pharma Ltd., Daewoong Pharmaceutical Co., Ltd., Iterum Therapeutics plc, ACS Dobfar S.p.A.

What are the deliverable formats of the Carbapenem Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Spero Therapeutics, Inc.
2. Savior Lifetec Corporation
3. Meiji Seika Pharma Co., Ltd.
4. Merck & Co., Inc.
5. Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.)
6. Aurobindo Pharma Ltd.
7. Daewoong Pharmaceutical Co., Ltd.
8. Iterum Therapeutics plc
9. ACS Dobfar S.p.A.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.